PT  - JOURNAL ARTICLE
AU  - Carrillo-Vega, María Fernanda
AU  - Salinas-Escudero, Guillermo
AU  - García-Peña, Carmen
AU  - Gutiérrez-Robledo, Luis Miguel
AU  - Parra-Rodríguez, Lorena
TI  - Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in México
AID  - 10.1101/2020.05.11.20098145
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.11.20098145
4099  - http://medrxiv.org/content/early/2020/05/14/2020.05.11.20098145.short
4100  - http://medrxiv.org/content/early/2020/05/14/2020.05.11.20098145.full
AB  - Background With its high prevalence of chronic non-degenerative diseases, it is suspected that in Mexico there is a high risk of fatal complications from COVID-19. The present study aims to estimate the risk factors for hospitalisation and death in the Mexican population infected by SARS-CoV-2.Methods and Findings We used the publicly available data released by the Epidemiological Surveillance System for Viral Respiratory Diseases of the Mexican Ministry of Health (Secretaría de Salud, SS). All records of positive SARS-CoV-2 cases were included. Two multiple logistic regression models were fitted to estimate the association between the hospitalisation and mortality, with other covariables. Data on 10,544 individuals (57.68% men), with mean age 46.47±15.62, were analysed. Men were about 1.54 times as likely to be hospitalized than women (p<0.001, 95% C.I. 1.37-1.74); individuals aged 50-74 and ≥74 years were more likely to be hospitalized than people from 25-49 years (OR 2.05, p<0.001, 95% C.I. 1.81-2.32, and OR 23.84, p<0.001, 95% C.I. 2.90-5.15, respectively). People with hypertension, obesity, and diabetes were more likely to be hospitalised than people without these morbidities (p<0.01). Men had more risk of death in comparison to women (OR=1.53, p<0.001, 95% C.I. 1.30-1.81) and individuals aged 50-74 and ≥75 years were more likely to die than people from 25-49 years (OR 1.96, p<0.001, 95% C.I. 1.63-2.34, and OR 3.74, p<0.001, 95% C.I. 2.80-4.98, respectively). Hypertension, obesity, and diabetes presented in combination, provided a higher risk of dying in comparison to not having these diseases (OR=2.10; p<0.001, 95% C.I. 1.50-2.93). Hospitalisation, intubation and pneumonia conferred a higher risk of dying (OR 5.02, p<0.001, 95% C.I. 3.88-6.50; OR 4.27, p<0.001, 95% C.I. 3.26-5.59, and OR=2.57; p<0.001, 95% C.I. 2.11-3.13, respectively). The main limitation of our study is the lack of information on mild (asymptomatic) or moderate cases of COVID-19.Conclusions The present study points out that in Mexico, where an important proportion of the population develops two or more chronic conditions simultaneously, high mortality is a sever outcome for those infected by SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by a grant from the Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico CM-SECTEI/041/2020 “Red colaborativa de Investigación Traslacional para el Envejecimiento Saludable de la Ciudad de Mexico” (RECITES). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be found from the Mexican Ministry of Health (Secretaria de Salud, SS) We downloaded the data available on 23rd. April 2020 https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid-19-en-mexico